Article
Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.
Annals of clinical biochemistry - 1 Jan 2008
Yoshida Shigeru, Hige Shuhei, Yoshida Miyuki, Yamashita Naoki, Fujisawa Shin-ichi, Sato Kaori, Kitamura Tadashiro, Nishimura Masaharu, Chuma Makoto, Asaka Masahiro, Chiba Hitoshi
Abstract excerpt
BACKGROUND: Lamivudine (LAM)-resistant hepatitis B virus (HBV) with mutations in the polymerase region frequently appears after long-term use of LAM. Several methods allowing detection of mutant strains (YIDD, YVDD) have been reported, but they have no quantitative characteristics. In this study, we explored a unique approach for quantification of each mutant strain. METHODS: A method for detection and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
